184 related articles for article (PubMed ID: 25748132)
1. Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects.
Bujor AM; El Adili F; Parvez A; Marden G; Trojanowska M
Front Immunol; 2020; 11():800. PubMed ID: 32508810
[TBL] [Abstract][Full Text] [Related]
2. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.
Kubo M; Czuwara-Ladykowska J; Moussa O; Markiewicz M; Smith E; Silver RM; Jablonska S; Blaszczyk M; Watson DK; Trojanowska M
Am J Pathol; 2003 Aug; 163(2):571-81. PubMed ID: 12875977
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis-Associated Interstitial Lung Disease.
Papazoglou A; Huang M; Bulik M; Lafyatis A; Tabib T; Morse C; Sembrat J; Rojas M; Valenzi E; Lafyatis R
Arthritis Rheumatol; 2022 Dec; 74(12):2003-2014. PubMed ID: 35849803
[TBL] [Abstract][Full Text] [Related]
4. Role of cellular senescence in the pathogenesis of systemic sclerosis.
Tsou PS; Shi B; Varga J
Curr Opin Rheumatol; 2022 Nov; 34(6):343-350. PubMed ID: 35979691
[TBL] [Abstract][Full Text] [Related]
5. Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic Vasculopathies.
Bodio C; Milesi A; Lonati PA; Chighizola CB; Mauro A; Pradotto LG; Meroni PL; Borghi MO; Raschi E
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474040
[TBL] [Abstract][Full Text] [Related]
6. The immune pathogenesis of scleroderma: context is everything.
Greenblatt MB; Aliprantis AO
Curr Rheumatol Rep; 2013 Jan; 15(1):297. PubMed ID: 23288576
[TBL] [Abstract][Full Text] [Related]
7. The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity.
Ko J; Noviani M; Chellamuthu VR; Albani S; Low AHL
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762589
[TBL] [Abstract][Full Text] [Related]
8. The Crosstalk between N-Formyl Peptide Receptors and uPAR in Systemic Sclerosis: Molecular Mechanisms, Pathogenetic Role and Therapeutic Opportunities.
Napolitano F; Rossi FW; de Paulis A; Lavecchia A; Montuori N
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542130
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling offers insights into the role of innate immune signaling in SSc.
Johnson ME; Pioli PA; Whitfield ML
Semin Immunopathol; 2015 Sep; 37(5):501-9. PubMed ID: 26223504
[TBL] [Abstract][Full Text] [Related]
10. Genetics of systemic sclerosis: an update.
Broen JC; Coenen MJ; Radstake TR
Curr Rheumatol Rep; 2012 Feb; 14(1):11-21. PubMed ID: 22102179
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetics of Systemic Sclerosis.
Gumkowska-Sroka O; Kotyla K; Kotyla P
Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790215
[TBL] [Abstract][Full Text] [Related]
12. Silica's silent threat: Contributing to skin fibrosis in systemic sclerosis by targeting the HDAC4/Smad2/3 pathway.
Tang B; Shi Y; Zeng Z; He X; Yu J; Chai K; Liu J; Liu L; Zhan Y; Qiu X; Tang R; Xiao Y; Xiao R
Environ Pollut; 2024 May; 355():124194. PubMed ID: 38782158
[TBL] [Abstract][Full Text] [Related]
13. The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview.
Fioretto BS; Rosa I; Romano E; Wang Y; Guiducci S; Zhang G; Manetti M; Matucci-Cerinic M
Ther Adv Musculoskelet Dis; 2020; 12():1759720X20918456. PubMed ID: 32523636
[TBL] [Abstract][Full Text] [Related]
14. A modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice.
Yang X; Liu C; Fujino M; Yang J; Li XK; Zou H
FEBS Open Bio; 2017 Sep; 7(9):1316-1327. PubMed ID: 28904861
[TBL] [Abstract][Full Text] [Related]
15. [A Uuifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 - the development of a new animal model of systemic sclerosis -].
Asano Y
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):475-87. PubMed ID: 25748132
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis.
Asano Y
Int J Biochem Cell Biol; 2015 Oct; 67():86-91. PubMed ID: 26055516
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.
Noda S; Asano Y; Nishimura S; Taniguchi T; Fujiu K; Manabe I; Nakamura K; Yamashita T; Saigusa R; Akamata K; Takahashi T; Ichimura Y; Toyama T; Tsuruta D; Trojanowska M; Nagai R; Sato S
Nat Commun; 2014 Dec; 5():5797. PubMed ID: 25504335
[TBL] [Abstract][Full Text] [Related]
18. Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features.
Asano Y
Med Mol Morphol; 2015 Sep; 48(3):123-8. PubMed ID: 25986681
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
